Information:
Fel:
ID
25284
Beskrivning
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00963703
Länk
https://clinicaltrials.gov/show/NCT00963703
Nyckelord
Versioner (1)
- 2017-08-30 2017-08-30 -
Uppladdad den
30 augusti 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT00963703
Eligibility Rheumatoid Arthritis NCT00963703
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00963703
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Rheumatoid Arthritis
Item
patients with documented rheumatoid arthritis by acr criteria
boolean
C0003873 (UMLS CUI [1])
disease length
Item
disease duration < 5 years
boolean
C0872146 (UMLS CUI [1])
Methotrexate | Hydroxychloroquine | Sulfasalazine | DMARD Single | Combined Modality Therapy
Item
may have previously been treated with methotrexate,hydroxychloroquine or sulfasalazine, either as a single dmard or in combination
boolean
C0025677 (UMLS CUI [1])
C0020336 (UMLS CUI [2])
C0036078 (UMLS CUI [3])
C0242708 (UMLS CUI [4,1])
C0205171 (UMLS CUI [4,2])
C0009429 (UMLS CUI [5])
C0020336 (UMLS CUI [2])
C0036078 (UMLS CUI [3])
C0242708 (UMLS CUI [4,1])
C0205171 (UMLS CUI [4,2])
C0009429 (UMLS CUI [5])
Tender joint count | Swollen joint count | Involvement with Knee joint Quantity
Item
tender joint count >= 6, swollen joint count >= 6, and one must be a knee
boolean
C0451530 (UMLS CUI [1])
C0451521 (UMLS CUI [2])
C1314939 (UMLS CUI [3,1])
C0022745 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0451521 (UMLS CUI [2])
C1314939 (UMLS CUI [3,1])
C0022745 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Adrenal Cortex Hormones Dose Stable U/day
Item
corticosteroids <= 10 mg per day permitted on stable doses for at least 4 weeks
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
Consent Arthroscopic synovial biopsy Quantity
Item
patients must consent to 2 arthroscopic synovial biopsy procedures
boolean
C1511481 (UMLS CUI [1,1])
C0578443 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0578443 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Severe allergy Monoclonal Antibodies | Anaphylaxis Severe Monoclonal Antibodies
Item
history of severe allergic or anaphylactic reactions to monoclonal antibodies
boolean
C2945656 (UMLS CUI [1,1])
C0003250 (UMLS CUI [1,2])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0003250 (UMLS CUI [2,3])
C0003250 (UMLS CUI [1,2])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0003250 (UMLS CUI [2,3])
rituximab
Item
previous treatment with rituximab
boolean
C0393022 (UMLS CUI [1])
Arava
Item
previous treatment with arava
boolean
C0718644 (UMLS CUI [1])
Injection of steroid
Item
injected with steroids within 4 weeks of day 1 of study
boolean
C1261311 (UMLS CUI [1])
Investigational New Drugs
Item
treatment with any investigational agent within 4 weeks of day of study
boolean
C0013230 (UMLS CUI [1])
Medical condition Severe | Disease Severe | Communicable Disease Severe
Item
any severe or significant medical condition or disease or known active infection
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0009450 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0205082 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0009450 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnancy or nursing at present
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])